Literature DB >> 12886157

Value of magnetic resonance imaging in the depiction of intravenous leiomyomatosis extending to the heart.

Murat Kocaoglu1, Nail Bulakbasi, M Sahin Ugurel, Fatih Ors, Cem Tayfun, Taner Ucoz.   

Abstract

Intravenous leiomyomatosis is a seldom neoplasia characterized by invasion of venous channels by a benign smooth muscle tumor originating either from a uterine myoma or from vessel wall. Extension to the heart may cause mechanical obstruction and is frequently misdiagnosed as a right-atrial myxoma. We present a case of recurrent intravenous leiomyomatosis with previous hysterectomy because of uterine leiomyoma which have different magnetic resonance characteristics than that of the former reports.

Entities:  

Mesh:

Year:  2003        PMID: 12886157     DOI: 10.1097/00004728-200307000-00033

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  4 in total

Review 1.  Evaluation of cardiac tumors with magnetic resonance imaging.

Authors:  Antonio Luna; Ramón Ribes; Pilar Caro; José Vida; Jeremy J Erasmus
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

2.  Retroperitoneal arteriovenous malformation extending through the inferior vena cava into the heart and causing inferior vena cava dissection.

Authors:  Yon Mi Sung; Yeon Hyeon Choe; Seung Woo Park; Pyo Won Park; Chang Ohk Sung
Journal:  Eur Radiol       Date:  2004-06-30       Impact factor: 5.315

Review 3.  Intracardiac leiomyomatosis: a comprehensive analysis of 194 cases.

Authors:  Bin Li; Xin Chen; Ya-Dong Chu; Ren-Yuan Li; Wei-Dong Li; Yi-Ming Ni
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-04-05

4.  Intravenous leiomyomatosis with intracardiac extension depicted on computed tomography and magnetic resonance imaging scans: A report of two cases and a review of the literature.

Authors:  Hanjiang Zeng; Zhongzi Xu; Lizhi Zhang; Y I Luo; Hui Chen; Hongji Zhu; Liqing Peng; Jianqun Yu
Journal:  Oncol Lett       Date:  2016-04-26       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.